Virus-like antigen display delivers a stand-alone danger signal through the BCR that circumvents tolerance
- bioRxiv. 2026 Apr 24:2026.04.23.720482. doi: 10.64898/2026.04.23.720482.
- 1. Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, California 94143.
- 2. Biomedical Sciences Graduate Program, University of California, San Francisco, California 94143.
- 3. Joseph Henry Laboratories of Physics, Princeton University, Princeton, NJ 08544.
- 4. Department of Pharmaceutical Sciences, 1007 E. Huron Street, University of Michigan, Ann Arbor, Michigan 48104.
- 5. current affiliation: Calico Life Sciences, South San Francisco, California 94080.
- 6. Department of Molecular Biology, Princeton University, Princeton, NJ 08544.
- 7. Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544.
- 8. Department of Biological Chemistry, 1150 W. Medical Center Dr., University of Michigan Medical School, Ann Arbor, Michigan 48109.
How B cells discriminate self from foreign antigens remains a central question, given inherent autoreactivity of the mature B cell receptor (BCR) repertoire. Soluble antigen (sAg) induces tolerance, whereas patterned antigen display on virus-like particles (pAg) triggers robust B cell responses that can proceed without T cell help. Here, we show how this divergence arises early in BCR signaling. Unlike sAg, pAg can bypass a Lyn-dependent negative feedback loop to trigger digital signaling, such that ultra-low concentrations of pAg produce strong and sustained CA2+ responses. Surprisingly, pAg drives maximal nuclear NF-κB but limited NFAT, whereas sAg does the opposite, reflecting differential production of diacylglycerol. Consequently, sAg induced an NFAT-dependent anergy program, whereas pAg evaded this state and instead engaged a cMyc-driven program that partially resembles a TLR-dependent danger response. Our findings reveal how proximal signaling directs distinct transcriptional fate to enable immunogenic B cell responses to virus-like antigen display.